Skip to content ↓

Support of Young Faculty Seen as Crucial

Phillip Sharp was 33 years old and an untenured faculty member at MIT when he made the discovery that won him this year's Nobel prize for physiology or medicine.

As a result, the importance of support for young scientists and MIT's commitment to that end was stressed at the press conference on Dr. Sharp's Nobel prize.

"Phil continues to do great work, but both he and all the rest of the senior faculty here have a great belief that the most exciting things get done by the junior people, as in this case," said Richard O. Hynes, professor of biology and director of the Center for Cancer Research.

As a result, said Dean of Science Robert J. Birgeneau, "we have a really key commitment institutionally here at MIT to the careers of young people, and we put a lot of energy into trying to provide optimal resources for young people to do unimpeded basic research."

To meet that goal, however, "we have to continue to receive appropriate support from industry and most especially the federal government, and I hope that that will continue into the indefinite future," said Dr. Birgeneau, who is also the Cecil and Ida Green Professor of Physics.


A version of this article appeared in the October 20, 1993 issue of MIT Tech Talk (Volume 38, Number 10).

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story